291 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
be guaranteed and there is no assurance that the company will achieve its financial guidance and long-term targets, that the company’s future clinical
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Based Targets (SBT) Published first Task Force on Climate Related Financial Disclosure (TCFD) Report Executed a second 15-year virtual power purchase
8-K
EX-99.1
mzrn 4elc3
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.1
jelh xjk4g
8 Jan 24
Regulation FD Disclosure
10:29am
SC TO-C
EX-99.4
r42id k4nvoe0lh
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
oksif4b24fw61
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
EX-99.1
vc3cc
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
b1r4dxlbgzl x64r
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
8-K
EX-99.2
0tb7vi 7eif47cem2
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
xi00ui3rzx0p
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
a16zr16hf16 hpzzw3
10 Oct 23
Additional proxy materials by non-management
6:48am
8-K
EX-99.2
aip516swvrhh
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
7m35rtg8 cn
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am